President Trump is considering reclassifying marijuana as a less dangerous drug, after pot companies have poured millions of dollars into Trump’s political groups https://t.co/vyblxz9jZw ...

Trump says he may downgrade marijuana’s federal classification, a move that could ease sales and access for medical use https://t.co/vsBsQvCJlH ...

Policy & Regulation - The industry is closely monitoring President Trump's consideration of reclassifying marijuana as a less dangerous drug [1] Political Influence - Marijuana companies have invested millions of dollars into Trump's political groups [1]

Marijuana is bad for the brain. I published a study on a thousand marijuana users. Every area of their brain is lower in activity.And just today, a study came out in the Journal of the American Medical Association on,027 marijuana users. um it decreased activity in the hippocampus that affected their memory centers. If you're a teenager and you use marijuana in your 20s, you have a higher incidence of anxiety, depression, and suicide.This is not innocuous. And we've been advertised this load of crap which i ...

Company Overview - Altria is a consumer staples company primarily focused on cigarette production, which is distinct from other consumer staples companies that produce essential goods like food and toiletries [1][2] - The company has a high dividend yield of 7.4%, attracting dividend-focused investors [1] Market Dynamics - Cigarettes are not considered a necessity, but their addictive nature leads to consistent demand, even during economic downturns [2] - Historical data shows that during the pandemic in 2020, cigarette volumes only declined by 0.4%, but subsequent years have seen significant volume declines [3][5] Volume Decline - Altria's cigarette volumes have experienced a troubling trend: a 7.5% decline in 2021, 9.7% in 2022, 9.9% in 2023, and a projected 10.2% drop in 2024 [5] - The ongoing decline in cigarette volume poses a significant risk to the company's financial health and dividend sustainability [6] Pricing Strategy - The company has been offsetting volume declines through price increases, which has allowed it to maintain and increase its dividend [6] - However, there are concerns that continued price hikes may exacerbate volume declines in the long run [6] Strategic Challenges - Altria has attempted to diversify its business beyond cigarettes, investing in vaping and marijuana, but these efforts have not yielded successful outcomes [7] - The company's latest investment in NJOY is facing legal challenges, further complicating its growth strategy [7] Investment Considerations - Altria is struggling with its core cigarette business and has not effectively transitioned to new growth platforms, making it a risky investment for dividend-focused investors [8]